Loading…
GC Wellbeing held a groundbreaking ceremony on November 2, 2026, for a medical device GMP plant in Eumseong, North Chungcheong Province, South Korea. The facility will produce dermal fillers and skin boosters, with completion targeted for the second quarter of 2027.
“GC Wellbeing plans to apply the aseptic manufacturing technology and GMP-based quality control capabilities it has built up running its prescription drug business, centered on Laennec and nutritional injections, to the new facility.”en.sedaily.com
Summarized from public sources; check the original articles before acting on it.